Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-05
DOI
10.1038/srep45983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The current status of checkpoint inhibitors in metastatic bladder cancer
- (2016) Omar Fahmy et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Pyruvate kinase M2 at a glance
- (2015) W. Yang et al. JOURNAL OF CELL SCIENCE
- Pyruvate kinase: Function, regulation and role in cancer
- (2015) William J. Israelsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
- (2015) Katharina Bluemlein et al. Oncotarget
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
- (2014) Woonyoung Choi et al. Nature Reviews Urology
- Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
- (2013) I. Andujar et al. CURRENT MEDICINAL CHEMISTRY
- Molecular mechanisms of cisplatin resistance in bladder cancer
- (2012) Ross M Drayton et al. Expert Review of Anticancer Therapy
- Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
- (2012) Michael S. Goldberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Warburg effect in 2012
- (2011) Jean-Pierre Bayley et al. CURRENT OPINION IN ONCOLOGY
- Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma
- (2011) Ke Gong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
- (2011) J Chen et al. ONCOGENE
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
- (2011) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Turning on a Fuel Switch of Cancer: hnRNP Proteins Regulate Alternative Splicing of Pyruvate Kinase mRNA
- (2010) M. Chen et al. CANCER RESEARCH
- Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
- (2010) Sybille Mazurek INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Human pyruvate kinase M2: A multifunctional protein
- (2010) Vibhor Gupta et al. PROTEIN SCIENCE
- Key concerns about the current state of bladder cancer
- (2009) Yair Lotan et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started